CClinicalTrials.gg
TerminatedNCT05982405Updated May 18, 2025

Long-term Effects of Inspiratory Muscle Training in Chronic Venous Insufficiency

An interventional study of Training group: Inspiratory muscle training and Control group: Thoracic expansion exercise in Chronic Venous Insufficiency, sponsored by Izmir Democracy University. Terminated at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-18.

Sponsored by Izmir Democracy University · Not applicable, Interventional, and Supportive care

Why this study was terminated
Patients could not be reached for long-term follow-up.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The long-term effectiveness of inspiratory muscle training, which is known in the literature to help venous return by increasing the pump effect of the diaphragm muscle, remains unclear in individuals with chronic venous insufficiency. For this reason, in this study, it was aimed to investigate the long-term results of inspiratory muscle training in individuals with chronic venous insufficiency.

Read the detailed description

Initial treatment of chronic venous insufficiency (CVI) includes conservative methods such as reducing symptoms and helping to prevent secondary problems and disease progression. If conservative methods fail, further treatments based on anatomical and physiological pathophysiological features should be applied. Treatment of CVI ranges from simple compression stockings to very complicated venous reconstructions. Physiotherapy applications also have an important place in the treatment of CVI and contain patient education, complex decongestive physiotherapy, intermittent pneumatic compression, compression garment, venous exercise programs, biomechanical stimulation therapy, proprioceptive neuromuscular facilitation, relaxation techniques and hydrotherapy methods.

Researches investigating the effectiveness of new physiotherapy applications in CVI are very limited. In one of these publications, the effects of inspiratory muscle training (IMT) and calf muscle exercise training (CMET) applied in addition to compression therapy (CT) on quality of life (QoL), venous filling time, disease severity, pain, edema, range of motion, muscle strength and functionality were investigated newly. IMT and CT were applied in group 1, CMET and CT were applied in group 2, and only CT was applied in group 3. As a result, groups of 1 and 2 showed more improvement in these outcomes compared to other groups. Acute effects of inspiratory muscle training in CVI was only shown in this study. The long-term effectiveness of inspiratory muscle training is still unclear in individuals with CVI. Therefore, this study aimed to investigate the long-term results of inspiratory muscle training in individuals with CVI.

02

Conditions studied

  • Chronic Venous Insufficiency

Browse trials for

Keywords

  • Venous Insufficiency
  • pain
  • edema
  • respiratory function tests
  • maximal respiratory pressures
  • exercise capacity
  • quality of life
03

In context

Venous Insufficiency

189 studies on the registry are indexed under Venous Insufficiency; 16 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 139 interventional studies indexed under Venous Insufficiency.

Browse Venous Insufficiency studies →

Lead sponsor

Izmir Democracy University is the lead sponsor of 73 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years of age or older
  • Volunteering to participate in the study
  • Diagnosed with chronic venous insufficiency using duplex ultrasound and being under standard medical treatment follow-up
  • Being in one of the C1, C2, C3, C4 or C5 stages according to the Clinical, Etiology, Anatomy and Pathophysiology (CEAP) classification

Exclusion criteria

Exclusion Criteria:

  • Acute deep vein thrombosis, active ulcers, psychiatric disorder requiring prior vessel ablation and/or prescription drug therapy,
  • Any history of chronic disease or deep vein thrombosis that may interfere with exercise capacity measurement,
  • Having SARS-CoV-2 (COVID-19) or any acute infection,
  • Being pregnant,
  • History of arterial disease,
  • Having advanced cardiorespiratory diseases, acute ulcer (\< 3 months) and diabetic ulcers.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Training group

    The individuals in the training group will be performed inspiratory muscle training using an inspiratory muscle training device (PowerBreathe®) at 30-50% of the maximal inspiratory pressure.

    Other: Training group: Inspiratory muscle training

  • Sham comparator
    Control group

    Individuals in the control group will be performed thoracic expansion exercises.

    Other: Control group: Thoracic expansion exercise

Interventions

  • OtherTraining group: Inspiratory muscle training

    The individuals in the training group will be performed inspiratory muscle training at 30-50% of the maximal inspiratory pressure. Inspiratory muscle training will be done using an inspiratory muscle training device (PowerBreathe®) that works with the threshold loading principle. Inspiratory muscle training will be done for 15 minutes per a session, 2 times per a day or, if tolerated, 30 minutes per a day and 1 time per a day, 5-7 days/week (one session under the supervision and the others at home), for a total of 6 weeks. Applications made at home will be followed with a diary.

    Also known as: Experimental: Training group

  • OtherControl group: Thoracic expansion exercise

    Individuals in the control group will be performed thoracic expansion exercises. Thoracic expansion exercises will be applied to individuals in an upright sitting position. In this position, individuals will place their hands on their lower ribs and then perform the cycle of "deep breathing + holding the deep breath for 3 seconds + slowly emptying all the breath" 3 times in a row. After this cycle, individuals will be asked to rest by taking 3-4 calm breaths. Immediately after, the individual will be asked to repeat the same cycle and repeat the cycle with calm breaths and rest until it reaches 10 repetitions. The individual will do this session 4 times a day. Individuals will do the first session of breathing exercises under supervision. In this way, incorrect exercise will be prevented. Other breathing exercise sessions will be done by individuals as a home program every day and 4 sessions a day during 6 weeks.

    Also known as: Sham Comparator: Control group

06

What researchers measure

Primary outcomes

  1. Maximal inspiratory pressure (MIP)

    The MIP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.

    Time frame: After 6-week training and 3 months after 6-week training ends.

Secondary outcomes

  1. Maximal expiratory pressure (MEP)

    The MEP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.

    Time frame: After 6-week training and 3 months after 6-week training ends.

  2. Forced vital capacity (FVC)

    Pulmonary function (Forced vital capacity (FVC)) will be evaluated with a spirometer.

    Time frame: After 6-week training and 3 months after 6-week training ends.

  3. Forced expiratory volume in the first second (FEV1)

    Pulmonary function (Forced expiratory volume in the first second (FEV1)) will be evaluated with a spirometer.

    Time frame: After 6-week training and 3 months after 6-week training ends.

  4. FEV1 / FVC

    Pulmonary function (FEV1 / FVC) will be evaluated with a spirometer.

    Time frame: After 6-week training and 3 months after 6-week training ends.

  5. Flow rate 25-75% of forced expiratory volume (FEF 25-75%)

    Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) will be evaluated with a spirometer.

    Time frame: After 6-week training and 3 months after 6-week training ends.

  6. Peak flow rate (PEF)

    Pulmonary function (Peak flow rate (PEF)) will be evaluated with a spirometer.

    Time frame: After 6-week training and 3 months after 6-week training ends.

  7. Pain Intensity measured with the Numerical Rating Scale.

    Pain intensity will be measured with the Numerical Rating Scale. This scale expresses the severity of pain with integers from 0 (no pain) to 10 (the worst possible pain).

    Time frame: After 6-week training and 3 months after 6-week training ends.

  8. Aerobic capacity

    The six-minute walk test (6-MWT) will be performed according to the criteria of the American Thoracic Society for the evaluation of aerobic capacity.

    Time frame: After 6-week training and 3 months after 6-week training ends.

  9. Lower extremity strength

    To determine lower extremity strength and functional mobility, the 30-second Sit-Up Test will be used in the chair.

    Time frame: After 6-week training and 3 months after 6-week training ends.

  10. Total quality of life score evaluated by Chronic Venous Disease Quality of Life Questionnaire

    The score will be evaluated using Chronic Venous Disease Quality of Life Questionnaire. Each question is scored on a 5-item Likert scale. Higher scores indicate better quality of life.

    Time frame: After 6-week training and 3 months after 6-week training ends.

07

Study locations

1 site
  • Izmir Democracy University
    İzmir, 35140, Turkey
08

References and documents

Publications

  • Aydin G, Yeldan I, Akgul A, Ipek G. Effects of inspiratory muscle training versus calf muscle training on quality of life, pain, venous function and activity in patients with chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1137-1146. doi: 10.1016/j.jvsv.2022.04.012. Epub 2022 Jun 14. PubMed 35710091 ↗
  • Weiss RA, Munavalli G. Endovenous ablation of truncal veins. Semin Cutan Med Surg. 2005 Dec;24(4):193-9. doi: 10.1016/j.sder.2005.10.006. PubMed 16387263 ↗
  • Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2005 May 10;111(18):2398-409. doi: 10.1161/01.CIR.0000164199.72440.08. No abstract available. PubMed 15883226 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05982405
Lead sponsor
Izmir Democracy University
Responsible party
Gulsah Bargi (Assoc. prof, Izmir Democracy University) — Principal investigator
First posted
Aug 8, 2023
Start date
Sep 15, 2023
Primary completion
Jun 30, 2024
Completion
Dec 30, 2024
Last update
May 18, 2025

Study contacts

GÜLŞAH BARĞI, Assoc. Dr.
study director · Izmir Democracy University
ÖZLEM ÇİNAR ÖZDEMİR, Assoc. Dr.
principal investigator · Izmir Democracy University
CEMRE GÖRÜNMEZOĞLU, MSc
principal investigator · Izmir Democracy University
DÜNDAR ÖZALP KARABAY, Prof. Dr.
principal investigator · Dokuz Eylul University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion